ELIAS Animal Health Reports USDA’s Full Approval of ELIAS Cancer Immunotherapy (ECI) for Canine Osteosarcoma
Shots:
- The USDA CVB has fully approved ELIAS Cancer Immunotherapy (ECI) for the treatment of bone cancer in dogs
- ECI (cell therapy) conditions the immune system to identify patient’s unique cancer & then deploys activated killer T cells to target and destroy cancer cells
- Additionally, ECI is available at 100 authorized US treatment centers & must be chosen by veterinarians before surgery to collect cancer tissue for manufacturing the treatment
Ref: Prnewswire | Image: ELIAS Animal Health
Related News:- ELIAS Animal Health to Initate Clinical Evaluation of T-Cell Therapy for Limb-Sparing Canine Osteosarcoma
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Ridhi is an avid secondary researcher who follows trends in the biopharmaceutical and healthcare sectors to curate engaging content for the global audience. She works as a news editor at PharmaShots and loves to read books and explore new destinations.
